RHYTHM PHARMACEUTICALS INC (RYTM) Stock Analyst Earnings Estimates
NASDAQ:RYTM - Nasdaq - US76243J1051 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 23.64M 650.48% | 77.428M 227.53% | 130.126M 68.06% | 178.88M 37.47% | 306.17M 71.16% | 552.85M 80.57% | 1.015B 83.59% | 1.498B 47.59% | 2.001B 33.58% | 1.759B -12.09% | 1.742B -0.97% | |
| EBITDA YoY % growth | -177.49M -5.09% | -182.599M -2.88% | -263.94M -44.55% | -179.986M 31.81% | -118.474M 34.18% | 6.671M 105.63% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -179.16M -5.35% | -184.357M -2.90% | -265.503M -44.02% | -166.118M 37.43% | -88.72M 46.59% | 142.49M 260.61% | 511.14M 258.72% | 922.15M 80.41% | 1.362B 47.70% | 1.212B -11.01% | 1.191B -1.73% | |
| Operating Margin | -757.87% | -238.10% | -204.04% | -92.87% | -28.98% | 25.77% | 50.36% | 61.56% | 68.07% | 68.90% | 68.37% | |
| EPS YoY % growth | -3.48 -2.05% | -3.20 8.05% | -4.49 -40.31% | -2.83 37.02% | -1.62 42.80% | 1.46 190.44% | 6.22 325.30% | 9.40 51.09% | 14.97 59.22% | 11.59 -22.59% | 9.19 -20.69% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.68 2.16% | -0.69 5.45% | -0.66 8.69% | -0.65 19.41% | -0.43 36.54% | -0.45 34.98% | -0.38 42.60% | 0.18 128.13% | 0.34 178.57% | 0.67 250.00% | 0.87 329.73% |
| Revenue Q2Q % growth | 44.506M 53.06% | 48.035M 44.46% | 52.653M 25.87% | 54.743M 67.39% | 68.34M 53.55% | 81.6M 69.88% | 106.59M 102.44% | 107.1M 95.64% | 122.4M 79.10% | 135.66M 66.25% | 151.98M 42.58% |
| EBITDA Q2Q % growth | -45.89M 74.44% | -51.153M -19.78% | -54.04M -36.15% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -41.818M 76.81% | -41.984M 4.33% | -39.909M 3.26% | -33.495M 28.74% | -14.892M 64.39% | 2.04M 104.86% | 14.28M 135.78% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.81 65.53% | -0.72 | -0.09 | -13.18% |
| Q4 2024 Q2Q % growth | -0.72 -2.86% | -0.73 | 0.01 | 0.76% |
| Q3 2024 Q2Q % growth | -0.73 3.95% | -0.82 | 0.09 | 11.07% |
| Q2 2024 Q2Q % growth | -0.69 15.85% | -0.73 | 0.04 | 5.17% |
| Q1 2024 Q2Q % growth | -2.35 -155.43% | -2.21 | -0.14 | -6.55% |
| Q4 2023 Q2Q % growth | -0.70 6.67% | -0.71 | 0.01 | 1.68% |
| Q3 2023 Q2Q % growth | -0.76 3.80% | -0.75 | -0.01 | -0.77% |
| Q2 2023 Q2Q % growth | -0.82 7.87% | -0.81 | -0.01 | -1.14% |
| Q1 2023 Q2Q % growth | -0.92 12.38% | -0.92 | 0.00 | 0.28% |
| Q4 2022 Q2Q % growth | -0.75 11.76% | -0.83 | 0.08 | 9.14% |
| Q3 2022 Q2Q % growth | -0.79 -12.86% | -1.02 | 0.23 | 22.60% |
| Q2 2022 Q2Q % growth | -0.89 -27.14% | -0.97 | 0.08 | 7.96% |
| Q1 2022 Q2Q % growth | -1.05 9.48% | -1.03 | -0.02 | -1.53% |
| Q4 2021 Q2Q % growth | -0.85 -7.59% | -0.93 | 0.08 | 8.71% |
| Q3 2021 Q2Q % growth | -0.70 9.09% | -0.82 | 0.12 | 14.92% |
| Q2 2021 Q2Q % growth | -0.70 1.41% | -0.70 | 0.00 | -0.50% |
| Q1 2021 Q2Q % growth | -1.16 -48.72% | 0.30 | -1.46 | -484.53% |
| Q4 2020 Q2Q % growth | -0.79 -1.28% | -0.82 | 0.03 | 3.19% |
| Q3 2020 Q2Q % growth | -0.77 25.96% | -0.82 | 0.05 | 5.64% |
| Q2 2020 Q2Q % growth | -0.71 42.74% | -0.85 | 0.14 | 16.53% |
| Q1 2020 Q2Q % growth | -0.78 7.14% | -0.86 | 0.08 | 9.13% |
| Q4 2019 Q2Q % growth | -0.78 | -0.91 | 0.13 | 14.33% |
| Q3 2019 Q2Q % growth | -1.04 | -1.09 | 0.05 | 4.84% |
| Q2 2019 Q2Q % growth | -1.24 | -0.89 | -0.35 | -38.71% |
| Q1 2019 Q2Q % growth | -0.84 | -0.77 | -0.07 | -8.47% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 32.704M 25.94% | 41.121M | -8.417M | -20.47% |
| Q4 2024 Q2Q % growth | 41.83M 72.61% | 39.254M | 2.576M | 6.56% |
| Q3 2024 Q2Q % growth | 33.251M 47.76% | 33.167M | 84K | 0.25% |
| Q2 2024 Q2Q % growth | 29.078M 51.28% | 29.365M | -287K | -0.98% |
| Q1 2024 Q2Q % growth | 25.967M 126.41% | 27.434M | -1.467M | -5.35% |
| Q4 2023 Q2Q % growth | 24.234M 175.70% | 25.888M | -1.654M | -6.39% |
| Q3 2023 Q2Q % growth | 22.504M 425.79% | 22.622M | -118K | -0.52% |
| Q2 2023 Q2Q % growth | 19.221M 111.92% | 15.329M | 3.892M | 25.39% |
| Q1 2023 Q2Q % growth | 11.469M 664.60% | 12.361M | -892K | -7.22% |
| Q4 2022 Q2Q % growth | 8.79M 382.97% | 7.169M | 1.621M | 22.61% |
| Q3 2022 Q2Q % growth | 4.28M 315.53% | 4.857M | -577K | -11.88% |
| Q2 2022 Q2Q % growth | 9.07M 3,259.26% | 2.635M | 6.435M | 244.21% |
| Q1 2022 Q2Q % growth | 1.5M 3,650.00% | 2.347M | -847K | -36.09% |
| Q4 2021 Q2Q % growth | 1.82M | 1.737M | 83K | 4.78% |
| Q3 2021 Q2Q % growth | 1.03M | 952.884K | 77.116K | 8.09% |
| Q2 2021 Q2Q % growth | 270K | 470.424K | -200.424K | -42.60% |
| Q1 2021 Q2Q % growth | 40K | 61.019M | -60.979M | -99.93% |
| Q3 2020 Q2Q % growth | 339.997K | -339.997K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3.68% | 0.37% | -2.5% | -5.71% |
| Revenue | -0.19% | -1.28% | -0.07% | -4.43% |